Waters Research and Development Expenses 2010-2024 | WAT
Waters annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Waters research and development expenses for the quarter ending September 30, 2024 were $0.045B, a 7.96% increase year-over-year.
- Waters research and development expenses for the twelve months ending September 30, 2024 were $0.180B, a 0.93% increase year-over-year.
- Waters annual research and development expenses for 2023 were $0.175B, a 0.71% decline from 2022.
- Waters annual research and development expenses for 2022 were $0.176B, a 4.65% increase from 2021.
- Waters annual research and development expenses for 2021 were $0.168B, a 19.59% increase from 2020.
| Waters Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $175 |
| 2022 | $176 |
| 2021 | $168 |
| 2020 | $141 |
| 2019 | $143 |
| 2018 | $143 |
| 2017 | $133 |
| 2016 | $125 |
| 2015 | $119 |
| 2014 | $108 |
| 2013 | $101 |
| 2012 | $96 |
| 2011 | $92 |
| 2010 | $84 |
| 2009 | $77 |
| Waters Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $45 |
| 2024-06-30 | $46 |
| 2024-03-31 | $45 |
| 2023-12-31 | $44 |
| 2023-09-30 | $42 |
| 2023-06-30 | $46 |
| 2023-03-31 | $43 |
| 2022-12-31 | $48 |
| 2022-09-30 | $43 |
| 2022-06-30 | $44 |
| 2022-03-31 | $40 |
| 2021-12-31 | $43 |
| 2021-09-30 | $42 |
| 2021-06-30 | $45 |
| 2021-03-31 | $38 |
| 2020-12-31 | $40 |
| 2020-09-30 | $35 |
| 2020-06-30 | $31 |
| 2020-03-31 | $35 |
| 2019-12-31 | $37 |
| 2019-09-30 | $34 |
| 2019-06-30 | $36 |
| 2019-03-31 | $35 |
| 2018-12-31 | $38 |
| 2018-09-30 | $35 |
| 2018-06-30 | $36 |
| 2018-03-31 | $34 |
| 2017-12-31 | $35 |
| 2017-09-30 | $34 |
| 2017-06-30 | $33 |
| 2017-03-31 | $31 |
| 2016-12-31 | $33 |
| 2016-09-30 | $30 |
| 2016-06-30 | $33 |
| 2016-03-31 | $29 |
| 2015-12-31 | $28 |
| 2015-09-30 | $31 |
| 2015-06-30 | $31 |
| 2015-03-31 | $29 |
| 2014-12-31 | $29 |
| 2014-09-30 | $27 |
| 2014-06-30 | $27 |
| 2014-03-31 | $25 |
| 2013-12-31 | $27 |
| 2013-09-30 | $24 |
| 2013-06-30 | $25 |
| 2013-03-31 | $25 |
| 2012-12-31 | $25 |
| 2012-09-30 | $24 |
| 2012-06-30 | $24 |
| 2012-03-31 | $23 |
| 2011-12-31 | $24 |
| 2011-09-30 | $23 |
| 2011-06-30 | $23 |
| 2011-03-31 | $22 |
| 2010-12-31 | $23 |
| 2010-09-30 | $21 |
| 2010-06-30 | $21 |
| 2010-03-31 | $20 |
| 2009-12-31 | $20 |
| 2009-09-30 | $19 |
| 2009-06-30 | $20 |
| 2009-03-31 | $18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.372B | $2.956B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $201.646B | 24.60 |
| Intuitive Surgical (ISRG) | United States | $191.920B | 100.34 |
| Edwards Lifesciences (EW) | United States | $44.778B | 28.43 |
| Alcon (ALC) | Switzerland | $42.567B | 28.48 |
| IQVIA Holdings (IQV) | United States | $36.345B | 20.02 |
| IDEXX Laboratories (IDXX) | United States | $34.155B | 40.22 |
| DexCom (DXCM) | United States | $31.470B | 47.39 |
| STERIS (STE) | Ireland | $20.602B | 23.72 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.912B | 0.00 |
| Hologic (HOLX) | United States | $16.503B | 17.82 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.421B | 13.78 |
| Sysmex ADR (SSMXY) | Japan | $11.599B | 36.37 |
| Globus Medical (GMED) | United States | $11.495B | 29.11 |
| Penumbra (PEN) | United States | $9.232B | 90.43 |
| Masimo (MASI) | United States | $9.157B | 44.31 |
| Glaukos (GKOS) | United States | $8.418B | 0.00 |
| Teleflex (TFX) | United States | $8.366B | 13.34 |
| Integer Holdings (ITGR) | United States | $4.558B | 25.83 |
| PROCEPT BioRobotics (PRCT) | United States | $4.359B | 0.00 |
| Veracyte (VCYT) | United States | $3.174B | 95.23 |
| Inari Medical (NARI) | United States | $3.163B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.555B | 14.75 |
| Nihon Kohden (NHNKY) | Japan | $2.490B | 18.91 |
| Tandem Diabetes Care (TNDM) | United States | $2.454B | 0.00 |
| TransMedics (TMDX) | United States | $2.101B | 66.60 |
| Elekta AB (EKTAY) | Sweden | $2.085B | 18.74 |
| Integra LifeSciences Holdings (IART) | United States | $1.752B | 9.15 |
| RxSight (RXST) | United States | $1.413B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.323B | 0.00 |
| Artivion (AORT) | United States | $1.230B | 81.50 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.037B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.743B | 12.62 |
| Mesa Laboratories (MLAB) | United States | $0.737B | 17.36 |
| AxoGen (AXGN) | United States | $0.736B | 0.00 |
| IRadimed (IRMD) | United States | $0.697B | 37.69 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.681B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.648B | 34.13 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.566B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.455B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.441B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.427B | 23.10 |
| Delcath Systems (DCTH) | United States | $0.383B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.339B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| Accuray (ARAY) | United States | $0.199B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| Nevro (NVRO) | United States | $0.152B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.133B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.120B | 12.88 |
| Spectral Diagnostics (EDTXF) | Canada | $0.100B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| 908 Devices (MASS) | United States | $0.071B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.064B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.060B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.045B | 0.00 |
| Neuronetics (STIM) | United States | $0.043B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |